Get started
Author

Sonja Krösser

Observed names: S Kroesser, S Krösser, S. Kroesser, S. Krösser, Sonja Kroesser
Institution: Novaliq (Germany)
ORCID: 0000-0003-2049-2076
Observed ORCID: 0000-0003-2049-2076
OpenAlex ID: A5012925663
NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction
2022 · Joseph Tauber, Gregg J. Berdy, et al. · Ophthalmology · 108
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease
2019 · David L. Wirta, Gail L. Torkildsen, et al. · Ophthalmology · 89
Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease
2023 · Esen K. Akpek, David L. Wirta, et al. · JAMA Ophthalmology · 82
PDF
NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study
2023 · John D. Sheppard, Fred Kurata, et al. · American Journal of Ophthalmology · 75
PDF
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
2017 · Philipp Steven, Albert J. Augustin, et al. · Journal of Ocular Pharmacology and Therapeutics · 67
PDF
A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease
2020 · Joseph Tauber, David L. Wirta, et al. · Cornea · 66
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study
2021 · John D. Sheppard, David L. Wirta, et al. · Cornea · 63
Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial
2020 · Doreen Schmidl, Ahmed M. Bata, et al. · Journal of Ocular Pharmacology and Therapeutics · 57
Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients
2023 · Lei Tian, Zuojun Gao, et al. · JAMA Ophthalmology · 52
Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics
2019 · Priyanka Agarwal, Darina Khun, et al. · The Ocular Surface · 48
Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study
2023 · Eugene E. Protzko, Bruce A. Segal, et al. · Cornea · 33
The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial
2012 · A Marquet, K Kupas, et al. · Clinical Pharmacology & Therapeutics · 32
PDF
A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye
2017 · Uta Gehlsen, Tobias Braun, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 31
PDF
Topical semifluorinated alkane-based azithromycin suspension for the management of ocular infections
2019 · Priyanka Agarwal, Jennifer P. Craig, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 30
Water-Free Cyclosporine Ophthalmic Solution vs Vehicle for Dry Eye Disease
2024 · Rongmei Peng, Ying Jie, et al. · JAMA Ophthalmology · 29
Effect of ceralifimod (ONO‐4641) on lymphocytes and cardiac function: Randomized, double‐blind, placebo‐controlled trial with an open‐label fingolimod arm
2015 · Sonja Krösser, Peter Wolna, et al. · The Journal of Clinical Pharmacology · 29
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma
2013 · A. Hollebecque, E. Deutsch, et al. · Investigational New Drugs · 28
Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial
2006 · Sonja Krösser, Roland Neugebauer, et al. · European Journal of Clinical Pharmacology · 25
Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects
2012 · Sonja Krösser, Anne Marquet, et al. · Biopharmaceutics & Drug Disposition · 24
Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects
2013 · Annick Seithel‐Keuth, Andreas Johne, et al. · Clinical Pharmacology in Drug Development · 20
Long-Term Safety and Efficacy of a Water-Free Cyclosporine 0.1% Ophthalmic Solution for Treatment of Dry Eye Disease: ESSENCE-2 OLE
2024 · David L. Wirta, Anat Galor, et al. · Cornea · 14
Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study
2019 · Philipp Eberwein, Sonja Krösser, et al. · Ophthalmic Research · 13
Preclinical characterization of water-free cyclosporine eye drops – Factors impacting ocular penetration ex vivo and in vivo
2023 · Priyanka Agarwal, Johannes Korward, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 9
Einfluss von Alterung auf Schweregrad und antientzündliche Therapie des experimentellen Trockenen Auges
2017 · Philipp Steven, Tobias Braun, et al. · Klinische Monatsblätter für Augenheilkunde · 9
Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials
2024 · Ahmad M. Fahmy, Jennifer S. Harthan, et al. · Frontiers in Ophthalmology · 8
PDF
Works count: 42
Citation count: 1,094
H-index: 20
I10-index: 22
Year
Topic
Type